[{"address1": "3655 Nobel Drive", "address2": "Suite 260", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "858 926 7655", "website": "https://darebioscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dar\u00e9 Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a vaginal thermosetting gel formulation for the delivery of live biotherapeutics; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Dar\u00e9 Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Ms. Sabrina Martucci Johnson", "age": 57, "title": "CEO, President, Principal Financial Officer, Secretary & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 641406, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. MarDee J. Haring-Layton", "age": 48, "title": "Chief Accounting Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 409800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Walters", "age": 69, "title": "Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Friend Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.1, "open": 2.09, "dayLow": 2.05, "dayHigh": 2.175, "regularMarketPreviousClose": 2.1, "regularMarketOpen": 2.09, "regularMarketDayLow": 2.05, "regularMarketDayHigh": 2.175, "payoutRatio": 0.0, "beta": 1.11, "forwardPE": -1.5588235, "volume": 154948, "regularMarketVolume": 154948, "averageVolume": 1561270, "averageVolume10days": 203890, "averageDailyVolume10Day": 203890, "bid": 2.09, "ask": 2.14, "bidSize": 2, "askSize": 3, "marketCap": 18762826, "fiftyTwoWeekLow": 1.83, "fiftyTwoWeekHigh": 9.19, "priceToSalesTrailing12Months": -1059.9868, "fiftyDayAverage": 2.4614, "twoHundredDayAverage": 2.96585, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 26574252, "profitMargins": 0.0, "floatShares": 13268548, "sharesOutstanding": 8850390, "sharesShort": 229708, "sharesShortPriorMonth": 46706, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.025999999, "heldPercentInsiders": 0.01028, "heldPercentInstitutions": 0.067090005, "shortRatio": 0.06, "shortPercentOfFloat": 0.026300002, "impliedSharesOutstanding": 8850390, "bookValue": -1.41, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -18603688, "trailingEps": -2.16, "forwardEps": -1.36, "lastSplitFactor": "1:12", "lastSplitDate": 1719792000, "enterpriseToRevenue": -1501.285, "enterpriseToEbitda": -1.489, "52WeekChange": -0.4028169, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 2.12, "targetHighPrice": 12.0, "targetLowPrice": 11.0, "targetMeanPrice": 11.66667, "targetMedianPrice": 12.0, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 5035006, "totalCashPerShare": 0.374, "ebitda": -17844168, "totalDebt": 3032713, "quickRatio": 0.272, "currentRatio": 0.343, "totalRevenue": -17701, "revenuePerShare": -0.002, "returnOnAssets": -0.63133997, "grossProfits": -14315235, "freeCashflow": -3913925, "operatingCashflow": -11585475, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 180.7954, "financialCurrency": "USD", "symbol": "DARE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "postMarketChangePercent": 3.7735927, "postMarketPrice": 2.2, "postMarketChange": 0.08000016, "regularMarketChange": 0.02, "regularMarketDayRange": "2.05 - 2.175", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1397136600000, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1561270, "fiftyTwoWeekLowChange": 0.28999984, "fiftyTwoWeekLowChangePercent": 0.15846986, "fiftyTwoWeekRange": "1.83 - 9.19", "fiftyTwoWeekHighChange": -7.0699997, "fiftyTwoWeekHighChangePercent": -0.76931447, "fiftyTwoWeekChangePercent": -40.28169, "dividendDate": 1500508800, "earningsTimestamp": 1755201600, "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "earningsCallTimestampStart": 1755203400, "earningsCallTimestampEnd": 1755203400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.16, "epsForward": -1.36, "epsCurrentYear": -1.59, "priceEpsCurrentYear": -1.3333333, "fiftyDayAverageChange": -0.34140015, "fiftyDayAverageChangePercent": -0.1387016, "twoHundredDayAverageChange": -0.8458502, "twoHundredDayAverageChangePercent": -0.28519654, "priceToBook": -1.503546, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": 0.95238, "regularMarketPrice": 2.12, "shortName": "Dare Bioscience, Inc.", "longName": "Dar\u00e9 Bioscience, Inc.", "corporateActions": [], "postMarketTime": 1755907197, "regularMarketTime": 1755892801, "exchange": "NCM", "messageBoardId": "finmb_423979060", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Dar\u00e9 Bioscience", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]